Pfizer Presents: Inclusive Research, More Equitable Medicine

 

Health inequity is the pandemic that has been chronically underlying.

Aida Habtezion CMO and Head of Worldwide Medical and Safety at Pfizer
Session

Pfizer Presents: Inclusive Research, More Equitable Medicine

Setup

The COVID-19 pandemic forced the world to grapple with a long-standing truth: that poor diversity in early and late stage medical research remains a major threat to health equity. Overcoming barriers and challenges to fair representation in research and development will not happen overnight, nor can it be achieved by a single institution. In order to pioneer lasting and sustainable changes in the way we conduct R&D, pharmaceutical companies and the broader research, medical, and patient communities need to come together—not only to assess current practices, but also to identify and address drivers of disparity. How can we apply the recent lessons of scientific innovations discovered in the pandemic to advance health equity?

Explore More

Health

529 ideas
Sorry, we couldn't find any results
Clear filters
Pfizer Presents: Inclusive Research, More Equitable Medicine

Thank you for signing up!

Please provide a valid email address.

Please provide a valid email address.
Newsletter
Newsletter
Sign up to receive the latest
updates from Aspen Ideas.